Skip to main content
Clinical Trials/DRKS00031901
DRKS00031901
Completed
Not Applicable

Characterisation of the skeletal muscles of patients with facioscapulohumeral muscular dystrophy by quantitative 1H and X-nuclei MRI - 23_FSDH_MRI_UKER

niversitätsklinikum Erlangen0 sites60 target enrollmentJune 14, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
G71.0
Sponsor
niversitätsklinikum Erlangen
Enrollment
60
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 14, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinikum Erlangen

Eligibility Criteria

Inclusion Criteria

  • Ambulant, at least for short distances.
  • \- Willingness and ability to participate, sufficient knowledge of German to understand the declaration of consent, or if not possible, test subject information and support in the mother tongue or, if necessary, in English
  • \- Probability that the subjects/patients can complete the study (defined by the ability to lie still for approximately 1 hour)

Exclusion Criteria

  • \- General contraindications for MRI examinations
  • \- Electrical implants such as cardiac pacemakers or perfusion pumps
  • \- Pronounced claustrophobia
  • \- Study participants with ferromagnetic or electrically conductive implants such as aneurysm clips, surgical clips, prostheses, artificial hearts, heart valves with metal parts, metal splinters, tattoos near the eye, symmetrical tattoos on the extremities or steel implants must be discussed with the study physician; they may not be examined (relative contraindications for MRI).
  • \- Prohibited concomitant medication: Strongly sedating medications are to be ruled out, since intensive monitoring of body functions during ongoing imaging cannot be guaranteed and the examination is dependent on the active participation of the subject.

Outcomes

Primary Outcomes

Not specified

Similar Trials